ABUS:NASDAQ
Arbutus Biopharma Corp
$5.07
arrow_downward
-1.93%(-0.100) 1D
$5.06
arrow_downward
-0.20% (-0.010)bedtimeAfter hours
Closed: Aug 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABUS...
Open
$5.15
High
$5.19
Low
$5.05
Mkt. cap
1.00B
Avg. vol.
2.94M
Volume
4.77M
P/E ratio
6.47
52-wk high
$5.45
52-wk low
$3.50
EPS
$0.78
Beta
0.64
Shares outstanding
197.85M
No. of employees
19
Open
$5.15
High
$5.19
Low
$5.05
Mkt. cap
1.00B
Avg. vol.
2.94M
Volume
4.77M
P/E ratio
6.47
52-wk high
$5.45
52-wk low
$3.50
EPS
$0.78
Beta
0.64
Shares outstanding
197.85M
No. of employees
19
Profile
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
About Arbutus Biopharma Corp
CEOWilliam H. Collier
Employees19
Founded2007
HeadquartersWarminster Township, Pennsylvania, United States
SectorBiotechnology
Websitearbutusbio.com
AI content may include mistakes. Learn more